 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 02/19/2021 |
$4.67 |
$4.85 |
$4.57 |
$4.75 |
2.38M | | 02/22/2021 |
$4.74 |
$5.10 |
$4.63 |
$4.89 |
3.48M | | 02/23/2021 |
$4.66 |
$4.72 |
$4.27 |
$4.68 |
2.83M | | 02/24/2021 |
$4.81 |
$4.87 |
$4.60 |
$4.71 |
995.20K | | 02/25/2021 |
$4.65 |
$4.65 |
$4.30 |
$4.39 |
924.20K |
|
|
| ARCA biopharma is a biopharmaceutical company focused on developing genetically-targeted therapies for cardiovascular diseases. Co.'s primary product candidate, Gencaro™ (bucindolol hydrochloride), is a pharmacogenetically-targeted beta-adrenergic receptor antagonist with mild vasodilator properties that Co. is developing to treat cardiovascular disease, focusing on atrial fibrillation in patients with chronic heart failure. Co. also has pharmacogenetic and other patent rights to drug candidates that have potential indications in cardiovascular disease, oncology and other therapeutic areas. | |
|
ARCA biopharma (ABIO) has the following price history information. Looking back at ABIO historical stock prices for the last five trading days, on February 19, 2021, ABIO opened at $4.67, traded as high as $4.85 and as low as $4.57, and closed at $4.75. Trading volume was a total of 2.38M shares. On February 22, 2021, ABIO opened at $4.74, traded as high as $5.10 and as low as $4.63, and closed at $4.89. Trading volume was a total of 3.48M shares. On February 23, 2021, ABIO opened at $4.66, traded as high as $4.72 and as low as $4.27, and closed at $4.68. Trading volume was a total of 2.83M shares. On February 24, 2021, ABIO opened at $4.81, traded as high as $4.87 and as low as $4.60, and closed at $4.71. Trading volume was a total of 995.20K shares. On February 25, 2021, ABIO opened at $4.65, traded as high as $4.65 and as low as $4.30, and closed at $4.39. Trading volume was a total of 924.20K shares.
ABIO Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARCA biopharma shares, starting with a $10,000 purchase of ABIO, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/28/2011 |
|
| End date: |
02/25/2021 |
|
| Start price/share: |
$2,336.04 |
|
| End price/share: |
$4.39 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-99.81% |
|
| Average Annual Total Return: |
-46.62% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$18.78 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 02/19/2021 | $4.75 | | 02/22/2021 | $4.89 | | 02/23/2021 | $4.68 | | 02/24/2021 | $4.71 | | 02/25/2021 | $4.39 |
|
|
